Pegteograstim prophylaxis for chemotherapy-induced neutropenia and febrile neutropenia: a prospective, observational, postmarketing surveillance study in Korea
- Abstract
- The prophylactic use of pegteograstim might have good overall safety and efficacy in patients with lymphomas and solid malignancies in routine clinical practice, even in those who are elderly and have liver and renal diseases.
- Issued Date
- 2021
- Type
- Article
- Keyword
- Anthracyclines; Cancer; Chemotherapy; Cyclophosphamide; Disease prevention; Drug therapy; Health aspects; Kidney diseases; Liver; Liver diseases; Lymphoma; Medical research; Medicine; Medicine & Public Health; Medicine; Experimental; Neutropenia Non-Hodgkin's lymphomas; Nursing; Nursing Research; Oncology; Original Article; Pain Medicine; Patients; Prednisolone; Rehabilitation Medicine; Side effects; Vincristine; Women
- URI
- https://oak.ulsan.ac.kr/handle/2021.oak/7069
https://ulsan-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=TN_cdi_proquest_miscellaneous_2499006595&context=PC&vid=ULSAN&lang=ko_KR&search_scope=default_scope&adaptor=primo_central_multiple_fe&tab=default_tab&query=any,contains,Pegteograstim%20prophylaxis%20for%20chemotherapy-induced%20neutropenia%20and%20febrile%20neutropenia:%20a%20prospective,%20observational,%20postmarketing%20surveillance%20study%20in%20Korea&offset=0&pcAvailability=true
- Publisher
- BMC CANCER
- Location
- 미국
- Language
- 영어
- ISSN
- 1471-2407
- Citation Volume
- 29
- Citation Number
- 9
- Citation Start Page
- 5383
- Citation End Page
- 5390
- Files in This Item:
-
-
There are no files associated with this item.
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.